Inhibition of vascular smooth muscle cell proliferation by the calcium antagonist clentiazem: Role of protein kinase C

Atherosclerosis

Volumn 126, Issue 2, 1996, Pages 207-219

  Alam, Rita ^a   Kataoka, Satoshi ^b   Alam, Syed ^a   Yatsu, Frank ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Calcium antagonist; Clentiazem; Hypertension; Proliferation; Protein kinase C; Smooth muscle cells

Indexed keywords

BOMBESIN; CALCIUM ANTAGONIST; CLENTIAZEM; DILTIAZEM; NIFEDIPINE; PHORBOL ESTER; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE C; VERAPAMIL;

ANIMAL CELL; AORTA; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0030601719     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05908-4     Document Type: Article

References (62)

1. 2+ channel blockers. Atherosclerosis. 88:1991;109.
2. Yatsu FM, Alam R, Alam S Enhancement of cholesteryl ester metabolism in cultured human monocyte-derived macrophages by verapamil. Biochem Biophys Acta. 847:1985;77.
3. Stein O, Leitersdorf E, Stein Y Verapamil enhances receptor-mediated endocytosis of low density lipoprotein by aortic cells in culture. Arteriosclerosis. 5:1985;35.
4. Ettingin OR, Hajjar DJ Nifedipine increase cholesteryl ester hydrolytic activity in lipid laden arterial smooth muscle cells. J Clin Invest. 75:1985;1554.
5. 2-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc Natl Acad Sci USA. 86:1989;2388.
6. Roth M, Emmons LR, Perruchoud A, Block LH Expressions of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes are stimulated by recombinant platelet-derived growth factor isomers. Proc Natl Acad Sci USA. 88:1991;1888.
7. 2+ channel blocker modulate expression of 3-hydroxy-3-methyl glutaryl-co enzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factors. Proc Natl Acad Sci USA. 88:1991;9041.
8. 2+ channel blockers involves protein kinase C isoform. Proc Natl Acad Sci USA. 90:1993;4097.
9. Narita H, Ginsberg R In-vitro study of the effect of clentiazem on rabbit aorta and on myocardium. Cardiovasc Drugs Ther USA. 4:1990;723.
10. Murata K, Kikawa K, Nagao T Cardiovascular effect of a new 1,5 benzothiezepine calcium antagonist in anesthetized dogs. Drug Res. 38:1988;521.
11. Gaddis RR, Mecca TE, Lacz JP Hypotensive effects on TA-3090 in conscious rabbits. FASEB J. 2:1988;795.
12. Suzuki T, Kurosawa H, Naito K, Otsuka M, Ohaeshi M, Takaiti O Binding characteristics of a new 1,5-benzothiezepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes. Eur J Pharmacol. 194:1991;195.
13. Sakaki T, Tsuzimoto S, Sasooka Y, Tsunoda S, Shintomi K The effect of a new calsium antagonist TA-3090 (clentiazem) on experimental transcient focal cerebral ischemia in cats. Stroke. 24:1993;872.
14. Kikkawa K, Nagao T Calcium antagonistic and plasmolytic activities of a new 1,5-benzothiazepine dericotine in isolated canine and monkey arteries. Drug Res. 38:1988;526.
15. Kaminow L, Bevan J Clentiazem reduces infarct size in rabbit middle cerebral artery occlusion. Stroke. 22:1991;242.
16. Nishizuka Y The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 334:1988;661.
17. Nishizuka Y Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607.
18. Schaap D, Van der Wal J, Howe LR, Marshall CJ, Van Blitterswijk WJ A dominant negative mutant of rat blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J Biol Chem. 268:1993;20232.
19. 2+-independent phorbol ester receptor. J Biol Chem. 265:1990;15704.
20. Ways DK, Cook PP, Webster C, Parkar PJ Effect of phorbol esters on protein kinase-C-zeta. J Biol Chem. 267:1992;4799.
21. Osada S, Mizuno K, Saido TCet al. A phorbol ester receptor/protein kinase nPKC eta, a new member of protein kinase C family predominantly expressed in lung and skin. J Biol Chem. 265:1990;22434.
22. Boynton AL, Whitfield JF, Isaacs RJ Calcium-dependent stimulation of BALB/c 3T3 mouse cell DNA synthesis by a tumor-promoting phorbol ester (PMA). J Cell Physiol. 87:1975;25.
23. Dicker P, Rozengurt E Stimulation of DNA synthesis by tumor promoter and pure mitogenic factors. Nature. 276:1978;723.
24. Rabin MS, Doherty PJ, Gottesman MN The tumor promoter phorbol 12-myristate 13-acetate induces a program of altered gene expression similar to that induced by platelet-derived growth factor and transforming oncogenes. Proc Natl Acad Sci USA. 83:1986;357.
25. Housey GM, Johnson MD, Hsiao WLW, O'Brian CA, Murphy JP, Kirschmeier P, Weinstein IB Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell. 52:1988;343.
26. Dempsey EC, McMurtry IF, O'Brien RF Protein kinase C activation allows pulmonary artery smooth muscle cells to proliferate to hypoxia. Am J Physiol. 260:1991;L136.
27. Niedel JE, Kuhn LJ, Vanderbank GR Phorbol diester receptor copurifies with protein kinase C. Proc Natl Acad Sci USA. 80:1983;36.
28. Nishizuka Y The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature. 308:1984;693.
29. Kikkawa U, Kishimoto A, Nishizuka Y The protein kinase C family: heterogeneity and its implications. Annu Rev Biochem. 58:1989;31.
30. Ross R, Glomset JA The pathogenesis of atherosclerosis. N Engl J Med. 295:1976;369.
31. Owens GK, Reidy MA Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation. Circ Res. 57:1985;695.
32. Schwartz SM, Campbell GC, Campbell SH Replication of smooth muscle cells in vascular disease. Circ Res. 58:1976;427.
33. Ross R, Raines EW, Bowen-Pope DE The biology of platelet derived growth factor. Cell. 46:1986;155.
34. Ross R The smooth muscle cell 11: growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 50:1971;172.
35. Laemmli UK Cleavage of structural protein during the assembly of the head of bacteriophage. Nature. 227:1970;680.
36. Towbin H, Stacheli T, Gordon J Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 76:1979;4350.
37. Erusalimsky JD, Friedberg I, Rozengurt E Bombesin, diacylglycerols, and phorbol eters rapidly stimulate the phosphorylation of an Mr = 80 000 protein kinase C substrate in permeabilized 3T3 cells: effect of guanine nucleotides. J Biol Chem. 263:1988;19188.
38. Takano T, Blank W, Peters T, deDuve C Assay, kinetics and lysosomal localization of an acid cholesteryl esterase in rabbit aortic smooth muscle cells. J Biol Chem. 249:1974;6732.
39. Hazzar D, Minick C, Fowler S Arterial neutral cholesteryl esterase: a hormone-sensitive enzyme distinct from lysosomal cholesteryl esterase. J Biol Chem. 258:1983;192.
40. 2. J Lipid Res. 24:1983;1176.
41. 2+, phospholipid-dependent protein kinase C associated with plasma membrane. Nature. 301:1983;621.
42. Berridge MJ Oncogenes, inositol lipids and cellular proliferation. Biotechnology. 2:1984;541.
43. 2+. Proc Natl Acad Sci USA. 84:1987;1950.
44. Lee MA, Bohm M, Paul M, Ganten D Tissue renin-angiotensin system. Their role in cardiovascular disease. Circulation. 87:1993;107.
45. Kariya K, Kawahara Y, Tsuda T, Fukuzaki H, Takai Y Possible involvement of protein kinase C in platelet-derived growth factor stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis. 63:1987;251.
46. 3H]phorbol 12,13-dibutyrate and phorbol ester induced differentiation of human promyelocytic leukemic cells. Proc Natl Acad Sci USA. 78:1981;1722.
47. 2+ sensitive phospholipid-dependent protein kinase activity in phorbol ester-treated cells. Biochem Biophys Res Commun. 120:1984;1053.
48. Young S, Parker PJ, Vidrich A, Stobel S Down-regulation of protein kinase C is due to an increased rate of degradation. Biochem J. 224:1987;775.
49. Huang CL, Ives HE Growth inhibition by protein kinase C late in mitogenesis. Nat Land. 29:1987;849.
50. Sharma RV, Bhalla RC PDGF-induced mitogenic signaling is not mediated through protein kinase C and c-fos pathway in VSM cells. Am J Physiol. 264:1993;C71.
51. Rozengurt E, Rodrigues-Pena M, Smith KA Phorbol ester, Phospholipase C and growth factors rapidly stimulate the phosphorylation of a Mr 80 000 protein on intact quiescent 3T3 cells. Proc Natl Acad Sci. 80:1983;2244.
52. Kariya K, Kawahara Y, Fukazaki Het al. The types of protein kinase C with different functions in cultured rabbit aortic smooth muscle cells. Biochem Biophys Res Commun. 161:1989;1020.
53. Leach KL, Powers EA, Ruff VA, Jaken S, Kauffman S Type 3 protein kinase C localization to the nuclear envelope of phorbol ester-treated NIH 3T3 cells. J Cell Biol. 109:1989;685.
54. Huang KP, Huang FL, Nakabayashi H, Yoshida Y Biochemical characterization of rat PKC isoenzymes. J Biol Chem. 163:1988;14839.
55. Li W, Mischak M, Yu TCet al. Tyrosine phosphorylation of protein kinase C-δ in response to its activation. J Biol Chem. 269:1994;2349.
56. Mitchell FE, Marais RM, Parker PJ The phosphorylation of protein kinase C as a potential measure of activation. Biochem J. 261:1989;131.
57. Molina CA, Ashendel CL Tumor promoter 12-0-tetradecanoyl phorbol-13-acetate and Sn-1, 2-dioctanoyl-glycerol increase the phosphorylation of protein kinase C in cells. Cancer Res. 51:1991;4624.
58. Grotta JC, Pettigrew LC, Rosenbaum D, Reid C, Rhoades H, McCandeles D Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats. Stroke. 19:1988;447.
59. Rosenbaum D, Zabramski J, Frey Jet al. Early treatment of ischemic stroke with calcium antagonists. Stroke. 22:1991;437.
60. Van Zweiten PA Protective effects of calcium antagonists in different organs and tissues. Am Heart J. 125:1993;566.
61. 2+ Channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats. Eur J Pharmacol. 279:1995;93.
62. Godfraind T, Miller R, Wibo M Calcium antagonism and calcium entry blockade. Pharmacol Rev. 38:1986;321.